Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Community news > Crick spinout to begin first-in-human clinical study for leukaemia

Crick spinout to begin first-in-human clinical study for leukaemia

GammaDelta Therapeutics has received Investigational New Drug approval from the US FDA for their GDX012 cell therapy to be investigated as a treatment for blood cancers. 
7 Jun 2021
United States of America
Community news

Featured

Clinicians

To view this News Article please log in or create a profile

Similar stories

Community news

Crick Community Chest awards funding to local projects

More...
A look back on Bring Your Culture to Work Day 2024

More...
More Crick postdocs awarded 2024 Marie Skłodowska-Curie Fellowships

More...

JASVEER PRESENTS AT THE CRICK SANDWICH STUDENT SYMPOSIUM
Looking back at our 2023 sandwich student placements

In June, we said farewell to 10 sandwich students who have completed a year-long placement at the Crick. More...
Crick Chief Biological Research Facility Officer awarded MBE

Huge congratulations to Sara Wells, Chief BRF Officer at the Crick who has been recognised in the King’s Birthday Honour… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


Check out

Community
Mentoring
Careers
News
Groups
Events

Legal

Terms
Privacy
Cookies
About
Contact

This website is powered by
ToucanTech